Fortis Healthcare launches Advanced Institute of Blood Disorders
(No Ratings Yet)
Loading...
Fortis Healthcare has announced the commencement of ‘Fortis Institute of Blood Disorders’. The hospital said that this dedicated to the specialised treatment of blood cancers and disorders, represents a critical step in addressing the urgent need for a comprehensive institute.
Designed to focus on the diverse spectrum of blood disorders, the Institute integrates paediatric and geriatric care, advanced transplant procedures, and hematopathology expertise, all under one roof. The Institute also introduces revolutionary CAR-T cell therapy, NexCAR19™ (Actalycabtagene autoleucel), to its extensive network of Bone Marrow Transplant centres in Mohali, Delhi, Gurgaon, Noida, Mumbai, and Bangalore. This initiative is supported by a commercial collaboration with ImmunoACT, an IIT-Bombay spin-off and pioneer in India’s first fully indigenous and commercially approved gene-modified cell therapy. NexCAR19™, India’s first market authorized CAR-T cell therapy, offers a new ray of hope for treating B-cell lymphomas and B-acute lymphoblastic leukaemia in patients aged 15 and above, who have previously found limited success with other treatments.
Dr. Ashutosh Raghuvanshi, MD & CEO, Fortis Healthcare, said: “The establishment of the Fortis Institute of Blood Disorders is a reflection of our unwavering commitment to medical excellence and patient-focused care. The integration of advanced CAR-T cell therapy across our Bone Marrow Transplant centres in India sets a new benchmark in the treatment of complex blood cancers. This initiative is a key part of our mission to offer the highest standard of care in precision medicine and comprehensive healthcare solutions.”
Speaking on the occasion, Dr. Virender Yadav, Chief Medical Officer of Gurugram, said: “The opening of the Fortis Institute of Blood Disorders is a pivotal moment, showcasing Fortis Healthcare’s dedication to tackling blood cancers and disorders. As Gurugram’s Chief Medical Officer, I am particularly impressed by the introduction of pioneering treatments like CAR-T cell therapy. This initiative enriches the entire medical landscape of Gurugram and beyond, enhancing the ability to provide advanced care for complex blood disorders.”
Comments